BIOGEN for BIOGEN
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, PET scan coverage and reimbursement, and dementia care Appropriations on Alzheimers screening and diagnosis Support for H.R.1520/S.1895 codifying the Purple Book Discussions regarding S.2546/H.R.2279, the Safe Step Act, patient access issues Support for H.R.6179 directing CMS to implement a shared savings model for biosimilars
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| STEPHANIE A. DYSON | — |
| JOHN RAYMOND GIBSON | — |
| MICHELLE MATHY | — |
| CHUCK SHIH | — |
| CAROLINE TUCKER | — |
Medicare/Medicaid MMM
Discussions regarding Medicaid 340B drug discount program Discussions regarding H.R.7647, to provide for a COVID-19-related delay regarding annual limitation on cost-sharing for group heath plans and individual and small group health insurance coverage
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY DEMSKE | — |
| CHRISTINA HOCHUL | — |
| MICHELLE MATHY | — |
Budget/Appropriations BUD
Discussions regarding H.R.133, the Consolidated Appropriations Act of 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| STEPHANIE A. DYSON | — |
| MICHELLE MATHY | — |
Pharmacy PHA
Education and discussions regarding pharmaceutical issues related to supply chain H.R.3/S.2543, Elijah E. Cummings Lower Drug Costs Now Act, discussions regarding support to increase Part B biosimilar payments from ASP +6% to ASP +8% of the reference product Advocate against inclusion of drug pricing as pay-fors in any COVID-19 relief package Oppose drug pricing proposals that include international procing index (IPI) or similar policies, Medicare drug negotiation, Medicare Part D redesign (including sections in H.R.3, S.2543, H.R.19. S.3129) Discussions regarding S.4295, Public Helath Emergency Pass-Through Payment Fairness Act of 2020
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| STEPHANIE A. DYSON | — |
| MICHELLE MATHY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.